| Literature DB >> 28564606 |
Subhash K Tripathi1, Zhi Chen2, Antti Larjo3, Kartiek Kanduri4, Kari Nousiainen5, Tarmo Äijo5, Isis Ricaño-Ponce6, Barbara Hrdlickova6, Soile Tuomela2, Essi Laajala2, Verna Salo2, Vinod Kumar6, Cisca Wijmenga6, Harri Lähdesmäki7, Riitta Lahesmaa8.
Abstract
The development of therapeutic strategies to combat immune-associated diseases requires the molecular mechanisms of human Th17 cell differentiation to be fully identified and understood. To investigate transcriptional control of Th17 cell differentiation, we used primary human CD4+ T cells in small interfering RNA (siRNA)-mediated gene silencing and chromatin immunoprecipitation followed by massive parallel sequencing (ChIP-seq) to identify both the early direct and indirect targets of STAT3. The integrated dataset presented in this study confirms that STAT3 is critical for transcriptional regulation of early human Th17 cell differentiation. Additionally, we found that a number of SNPs from loci associated with immune-mediated disorders were located at sites where STAT3 binds to induce Th17 cell specification. Importantly, introduction of such SNPs alters STAT3 binding in DNA affinity precipitation assays. Overall, our study provides important insights for modulating Th17-mediated pathogenic immune responses in humans.Entities:
Keywords: ChIP-seq; SNP; STAT3; Th17 cell differentiation; human
Mesh:
Substances:
Year: 2017 PMID: 28564606 DOI: 10.1016/j.celrep.2017.05.013
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423